# Pharmacokinetic Study To Evaluate Effect of Food and Diurnal Variation on ABT-869

> **NCT00733187** · PHASE1 · COMPLETED · sponsor: **AbbVie (prior sponsor, Abbott)** · enrollment: 34 (actual)

## Conditions studied

- Advanced Solid Tumors

## Interventions

- **DRUG:** ABT-869

## Key facts

- **NCT ID:** NCT00733187
- **Lead sponsor:** AbbVie (prior sponsor, Abbott)
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-02
- **Primary completion:** 2012-06
- **Final completion:** 2012-06
- **Target enrollment:** 34 (ACTUAL)
- **Last updated:** 2017-11-21

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00733187

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00733187, "Pharmacokinetic Study To Evaluate Effect of Food and Diurnal Variation on ABT-869". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00733187. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*